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 ABSTRACT
Background: Protein-energy wasting is a very common complication in hemodialysis patients and 
influences their survival. All hemodialysis patients should have their nutritional status evaluated regularly 
using multiple methods. The bioelectrical impedance analysis has been widely used in the nutritional 
assessment. The objective of this study was to evaluate, for a period of 7 years, to the prognostic value 
of the parameters of bioelectrical impedance analysis on mortality in hemodialysis patients. Methods:
A retrospective, observational study, including 301 patients in hemodialysis at baseline. During the study 
period 96 patients died, 46 patients were transplanted, 21 were not followed by Nutritionist, 49 were 
transferred to another clinic and 4 underwent treatment changes. The parameters assessed at baseline 
were: demographic and clinic data (age, gender, etiology of chronic kidney disease and co-morbidity), 
dialysis data (type and duration of hemodialysis, dialysis vintage, vascular access and Kt/V), biochemical 
parameters, body mass index, bioelectrical impedance analysis, subjective global assessment and PNAn. 
Results: According to Kaplan-Meier, Mantel-Hansel and Cox regression analysis the following variables 
were predictors of mortality: age, dialysis vintage, body mass cell index<8 kg/m2, phase angle<4.9º, 
extracellular mass/body cell mass ratio and PNAn<1.2 g/kg/day were selected as potential predictors of 
mortality. In multivariate analysis, after adjusting for others mortality risk factors (age, dialysis vintage, 
serum albumin, PNAn, inflammatory state, presence of diabetes and cardiovascular co-morbidity), only 
patients with lower phase angle were found to be at high risk for mortality. Conclusion: The present 
study shows that bioelectrical impedance analysis parameters (phase angle, body mass cell index and 
extracellular mass/body cell mass ratio) and PNAn were the only nutritional markers associated with 
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 INTRODUTION
Protein energy wasting (PEW) is extremely com-
mon in hemodialysis (HD) patients. Several studies 
have shown that nutritional markers are associated 
with patient survival in HD1,2. As no single clinically 
applicable parameter provides a conclusive indica-
tion of protein-energy nutritional status, international 
guidelines recommended the use of multiple nutri-
tional markers3,4. The International Society of Renal 
Nutrition and Metabolism (ISRNM) published a con-
sensus statement defining which elements describe 
protein-energy nutritional status4. It describes four 
categories: serum chemistry, body mass, muscle 
mass and dietary intake. Thus, assessment of body 
composition should be made through techniques 
such as Dual-energy X-ray absorptiometry (DEXA), 
bioelectrical impedance analysis (BIA) or anthro-
pometry5. While DEXA are not readily available in 
daily practice, BIA is an evolving method for longi-
tudinal cross sectional assessment of nutritional 
status5. BIA is a useful but disputed method for 
quantifying body composition. In HD patients with 
daily changing hydration status it is difficult to 
mortality in this cohort of hemodialysis patients. Therefore we conclude that the bioelectrical impedance 
analysis is a promising technique for assessing the nutritional status of patients on hemodialysis and 
may be used as a prognostic indicator of mortality in this population.
Key-words: Bioelectrical impedance analysis; mortality; nutritional assessment; protein energy wasting.
 RESUMO
Introdução: A desnutrição proteico-energética é uma complicação comum nos doentes em hemodiálise 
e influencia a sua sobrevivência. A avaliação nutricional deve ser feita regularmente em todos os 
doentes utilizando vários métodos. A bioimpedância tem sido amplamente utilizada na avaliação nutri-
cional destes doentes. O objetivo deste estudo é avaliar o valor prognóstico dos parâmetros da bio-
impedância na mortalidade dos doentes em hemodiálise, durante um período de 7 anos. Métodos: 
Estudo retrospectivo, observacional, que incluiu, no início do estudo, 301 doentes em hemodiálise. 
Durante o período de estudo 96 doentes faleceram, 21 não foram seguidos por Nutricionista, 46 foram 
transplantados, 49 foram transferidos de clínica e 4 de tratamento. Parâmetros avaliados no início do 
estudo: dados demográficos e clínicos (idade, género, etilologia da doença renal e comorbilidades), 
dados da diálise (tipo e duração da hemodiálise, tempo, acesso vascular e Kt/V) bioimpedância, aval-
iação subjetiva global, parâmetros bioquímicos, índice de massa corporal e PNAn. Resultados: De 
acordo com a análise de Kaplan-Meier, Mantel-Haenszel e regressão de Cox, foram considerados predi-
tores de mortalidade os seguintes parâmetros: idade, tempo de diálise, índice de massa celular<8kg/
m2, ângulo de fase<4.9º, relação água extracelular/massa celular e PNAn<1,2g/kg/dia. Na análise multi-
variada, depois do ajuste da mortalidade para outros parâmetros (idade, tempo de diálise, albumina 
sérica, PNAn, estado inflamatório, presença de diabetes e co-morbilidades cardiovasculares) apenas o 
ângulo de fase foi considerado um preditor de mortalidade no período estudado. Conclusão: Neste 
estudo os parâmetros avaliados por bioimpedância (ângulo de fase, índice de massa celular e relação 
água extracelular/massa celular) e a PNAn são marcadores nutricionais associados com a mortalidade 
nesta amostra. Concluímos que a bioimpedância constitui uma técnica promissora de avaliação do 
estado nutricional dos doentes em hemodiálise, podendo ser utilizada como indicador de prognóstico 
de mortalidade nesta população.
Palavras-chave: Avaliação nutricional; bioimpedância; desnutrição proteico-energética; mortalidade.
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Predictive value of bioelectrical impedance analysis parameters 
in the mortality of patients on haemodialysis
evaluate malnutrition. BIA is based on electrical 
properties of biological tissues, where impedance 
is the measure of the opposition to the flow of an 
alternating current and expressed by tissue resis-
tance and reactance6,7. Impedance is low in lean 
tissues, where intra and extracellular fluids and 
electrolytes are primarily contained, and high in 
bone, air-filled space and adipose tissue. In general, 
impedance is proportional to total body water. The 
phase angle (PA) is derived from the tangent arch, 
between reactance and resistance, measured by BIA, 
so it does not depend on parameters such as the 
height and weight of the patient. Smaller PA sug-
gests cell death or decreased cell integrity, whereas 
larger PA suggests higher quantities of intact cell 
membranes. It can also be interpreted as an indica-
tor of water distribution between the extra and 
intracellular spaces. The PA has been found to be 
a prognostic marker in several clinical conditions 
such as the human immunodeficiency virus infection, 
liver cirrhosis, chronic obstructive pulmonary dis-
ease, sepsis, cancer, systemic sclerosis and HD 
patients8. The body cell mass (BCM), which is a 
metabolically active component of fat-free mass 
(FFM), is the single best predictor of patients’ nutri-
tional status. The body cell mass index (BCMI), which 
is calculated from BCM dividing by height squared 
(kg/m2), has been shown to be more sensitive to 
changes in protein status and lean tissue compared 
to body mass index (BMI). The muscle mass (MM) 
depletion in certain pathologic conditions can be 
best described by the loss of BCM9. Extracellular 
mass (ECM) contain all the body´s metabolically 
active tissues. Extracellular mass/body cell mass ratio 
(ECM/BMC) is a highly sensitive index of malnutrition 
and hydration10. The current study aimed to evaluate 
the relationship between nutritional markers deter-
mined by BIA and other nutritional markers and 
assess the prognostic value of the parameters of 
bioelectrical impedance analysis on mortality in HD 
patients.
 SUBJECTS AND METHODS
An observational, retrospective, multicenter study, 
to assess the nutritional status of 301 patients on 
HD. The patients mean follow up was 56.8±29.2 
months (min. 2; max. 84 months) between 2004 and 
2011.
Sample: At baseline (year 2004) 394 HD patients 
were randomly selected from dialysis centres locat-
ed in Mirandela, Gondomar, Porto and Santa Maria 
da Feira. Exclusion criteria were: serum albumin < 
2.6 g/dl, pace-maker, asymmetrical patients (such 
as amputees), dermatological diseases, or patients 
with creatinine clearance > 5.0ml/min/1.73m2. All 
patients have received detailed nutritional informa-
tion by Nutritionist and have signed an informed 
consent. There were included in the study only 301 
patients. During the study period (2004-2011): 96 
patients died, 46 patients were transplanted, 21 
were not followed by Nutritionist, 49 were trans-
ferred to another clinic and 4 underwent treatment 
changes.
Demographic and clinic data: age, gender, etiol-
ogy of chronic kidney disease and presence of 
co-morbidity.
Dialysis data: type of HD, dialysis vintage, dura-
tion of HD and vascular access. The adequacy of 
dialysis was calculated by single-pool Kt/V.
Laboratory procedure: We measured the pre-
dialysis serum concentrations of: serum albumin_ 
Alb, total cholesterol_ Tcol, serum creatinine_ 
Creat, C-reactive protein_ CRP; using standard 
laboratory techniques. Inflammatory state was 
considered present when the value of CRP was 
higher than 0.6 mg/dl. The measurement of dietary 
protein intake was the normalized protein nitrogen 
appearance (PNAn), calculated using the equation 
published by National Kidney Foundation (NKF) 
and Kidney Disease and Dialysis Outcome Quality 
Iniciative (K/DOQI)3.
Anthropometric measurements: body weight, 
height, body mass index_ BMI (calculated based on 
dry weight).
Bioelectrical impedance analysis: was performed 
before and after a mid-week dialysis, with a portable 
derivate model BIA 101, using Bodigram S.R.I. Biore-
search® – AKERN v.1.3. In order to determine resist-
ance (R) and reactance (XC), the patient received 
an electrical current of 800 µA at 50 kHz. The soft-
ware calculated the following parameters: phase 
angle_ PA (°), ECM/BCM, BMC (kg and %), FFM (kg 
and %), body fat _ BF (kg and %), MM (kg and %) 
and BCMI (kg/m2).
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Subjective global assessment: SGA was guided 
by a scale of 7 points (NECOSED). Patients with 
adequate nutritional status patients were classified 
with scores between 6 and 7, mild or moderate PEW 
received scores between 3 and 5 and severe PEW 
received scores between 1 and 2.
The study was approved by the Ethic Committee 
of Faculty of Medicine, University of Porto/”Hospital 
São João” (CHSJ), Porto, Portugal and (at baseline, 
in year 2004) by the ethic committee of Fresenius 
Medical Care (Portugal).
Statistical analysis: The results were expressed 
as mean ± standard deviation or in absolute and 
relative frequency (n, %). The program SPSS 21.0 
® for Windows (IBM) was used to calculations 
t-Student test, Mann-Whitney for independent 
samples, compared by sex and survivor and non 
survivor groups, and the degree of association 
between the variables by Pearson’s correlation 
coefficient (r). The outcome of interest in the 
present study was mortality. Odds ratios and 
95% confidence interval were calculated. The 
Kaplan-Meier method was used to calculate cumu-
lative survival probabilities, and the difference 
between survival curves was assessed by long-
rank test. Cox´s proportional hazards model 
(backward method) was used to evaluate inde-
pendent predictors of survival. Hazard ratios (HR) 
and 95% confidence intervals (95% CI) were 
calculated. Difference was considered statistically 
significant when two-tailed p value was less than 
0.05.
 RESULTS
 Descriptive results
At baseline, the study included 301 patients (185 
men, 116 women) with average age 62.3 ± 13.9 years 
old. These patients were in HD for about 4.8 ± 4.5y. 
The prevalence of diabetes was 25.9% in all patients. 
Most patients performed high flux HD (72.1%), three 
times/week (95,3%), with an average of 11.5±1,1 hours 
of HD per week.
During the period of study 96 patients have 
died (53%), 46 patients (15.2%) were transplanted, 
21 (6,9%) were not followed by Nutritionist, 49 
(16.2%) were transferred to another clinic and 4 
(1.4%) underwent treatment change. The results 
shown are from the study of a total of 181 patients 
on HD therapy (99 men, 82 women) with average 
age 65.8 ± 12 years old. The causes of end-stage 
renal disease were diabetic nephropathy (23.2%), 
hypertensive nephrosclerosis (11.6%) and others 
(65.2%). Regarding HD access, 82.9% of patients 
had a native arteriovenous fistula and 17.1% had 
a central venous catheter. Most patients per-
formed high flux HD (87.8%), three times/week 
(95%) for 4 hours. The median dialysis vintage 
was 3.9 years (range: 0.5 to 24.4 years). Demo-
graphic, laboratory and nutritional data of incident 
HD patients are presented in following table 
(Table I).
The prevalence of PEW varies according to the 
criteria used for its diagnosis (SGA<6 points: 11%; 
Alb<4.0 g/dl: 68%; Alb<3.8 g/dl: 29.3%; Alb<3.6 g/dl: 
13.3%; Tcol<150 mg/dl: 46.4%; Tcol<100 mg/dl: 5.5%, 
BMI<23 kg/m2: 40.3%, BMI<18.5 kg/m2:2.8; 
BCMI<8.0 kg/m2: 49.7%; PA<6.4º:78.5%; PA<6º:65.2%; 
PA<4º:7.2%.
Thirty-seven point four percent of patients have 
inflammatory state (CRP>0.6 mg/dl).
Fifty-nine percent of patients (n=107) had a BMI 
between 18.5 and 25 kg/m2, 38.1% (n=69) were 
overweight or obese (BMI≥25 kg/m2), and only 
2.8% (n=5) were underweight. Comparing male 
and female groups, Creat, FFM (%) and dialysis 
vintage were significantly lower in female group. 
In contrast, Tcol, BMI, BF (%) and Kt/V were higher 
in this group.
No difference was observed in serum albumin 
concentration, SGA, PA, BCM, BCMI and ECM/BCM 
ratio. Dietary protein intake was similar between 
male and female groups. However, in 57,5% of 
patients the protein intake was below the 
recommendation3.
 Association between nutritional marker assessed 
by BIA and other nutritional parameters
The PA, assessed by BIA, correlates positively 
with: Alb (r=0.40; p<0.001), Creat (r=0.30; p<0.001), 
Rosária Rodrigues, Bruno Oliveira, Sofia Pedroso, J. Nunes Azevedo, Pedro Azevedo, J. P. Oliveira,  
Fátima Silva, Francisco Travassos, Tânia Rodrigues, Orlando Pereira, Arlindo Azevedo, Rui Castro, Flora Correia
Nefro - 28-4 - MIOLO.indd   312 29/12/2014   14:18:24
Port J Nephrol Hypert 2014; 28(4): 309-317    313
CMYKP
SGA (r=0.56; p<0.001) and BMI (r=0.28; p<0.001). 
Correlates negatively with CRP (r= -0.12; p<0.001).
The BCMI correlates positively with: Alb (r=0.45; 
p<0.001), Creat (r=0.34; p<0.001), SGA (r=0.54; 
p<0.001) and PNAn (r=0.31; p<0.001). Correlates 
negatively with CRP (r=-0.16; p<0.001).
The ECM/BCM ratio correlated inversely with: Alb 
(r= – 0.35; p<0.001), Creat (r= -0.99; p<0.001), SGA 
(r= -0.47; p<0.001) and PA (r= -0.74; p<0.001).
 Comparison between survivors and non survivors
Comparing survivor and non survivor groups, age, 
dialysis vintage, ECM/BCM and CPR were significantly 
higher in non survivor group. In contrast, BCMI, PA 
and PNAn were lower in this group. No difference 
was observed in: sex, presence of diabetes, SGA, 
BMI, laboratory parameters (Alb, Creat and Tcol), 
dose of dialysis and BIA parameters (BF, FFM and 
BMC). All characteristics of survivor and non survivor 
patients was presented in Table II (Table II).
Predictive value of bioelectrical impedance analysis parameters 
in the mortality of patients on haemodialysis
Table I
Patient characteristics (n=181) 
Parameters Total
(n =181) 
Male
(n = 99)
Female (n = 82)  p*; p* 
Demographic
Age (years) 65.8±12.0 (Median = 68 y) 65.3±12.0 (Median = 67 y) 66.3±12.0 (Median = 69 y)
n.s *
Parameters of protein -energy nutritional status
SGA Classification <6
Well nourished
Mild to moderate malnutrition
Severe malnutrition
6.6 ± 0.4
161 (89%)
20 (11%)
0 (0%)
6.5 ± 0.4
88 (88.9%)
11 (11.1%)
0 (0%)
6.6 ± 0.4
73 (89%)
9 (11%)
0 (0%)
n.s.*
n.s.**
n.s.**
n.s.**
Serum albumin (g/dl)
Alb < 4.0 (n; %)
Alb < 3.8 (n; %)
Alb < 3.6 (n; %)
3.8 ± 0.3
123 (68%)
53 (29.3%)
24 (13.3%)
3.8 ± 0.2
53 (64.6%)
22 (26.8%)
13 (15.9%)
3.8 ± 0.3
70 (70.7%)
31 (31.3%)
11 (11.1%)
n.s.*
n.s.**
n.s.**
n.s.**
Serum creatinine (mg/dl) 8.6 ± 2.5 8.9 ± 2.5 8.3 ± 2.3 n.s.*
Total cholesterol (mg/dl)
Tcol < 150 (n; %)
Tcol < 100 (n; %)
152.8±34.5
84 (46.4%)
10 (5.5%)
147.2±36.5
50 (50.5%)
9 (9.1%)
159.4±30.8
34 (41.5%)
1 (1.2%)
<0.05*
n.s.**
<0.05**
PNAn (g/kg/day)
PNAn < 1.2 (n; %)
1.0 ± 0.2
104 (57.5%)
1.0 ± 0.1
61 (61.6%)
1.1 ± 0.2
43 (52.4%)
n.s.*
n.s.**
Body mass index (kg/m2)
BMI < 23 (n; %)
24.3±3.8
73 (40.3%)
23.5±3.3
47 (47.5%)
25.4±4.3
26 (31.7%)
<0.01*
<0.05**
Phase angle (º) _BIA
PA < 6.4 (n; %)
PA <5.9 (n; %)
PA<5.5 (n;%)
PA<4.9 (n; %)
5.6 ± 1.2
142 (78.5%)
110 (60.8%)
85 (47%)
13 (7.2%)
5.6 ± 1.4
75 (75.8%)
57 (57.6%)
47 (47.5%)
26 (26.3%)
5.5 ± 1.0
67 (81.7%)
53 (64.6%)
38 (46.3%)
15 (18.3%)
n.s.*
n.s.**
n.s.**
n.s.**
n.s.**
Body mass cell mass (kg/m2) – BIA
BCMI < 8
7.6±1.9
90 (49.7%)
7.5±1.9
55 (55.6%)
7.7±1.8
35 (42.7%)
n.s.*
n.s.**
Body Fat (%) 32.9±9.0 29.5±8.0 37.1±8.6 <0,001*
Fat -free mass (%) 67.0±9.0 70.5±8.0 62.9±8.7 <0,001*
Body mass cell (kg) 22.0±6.9 23.4±7.3 20.5±6.0 n.s.*
Extracellular mass/body cell mass ratio 1.0±0.2 1.0±0.2 1.0±0.2 n.s*
Other clinical parameters
Dialysis vintage (years) 4.9±4.7 (Median=3.9 y) 5.5±4.9 (Median=4.3 y) 4.2±4.2 (Median=2.8 y) <0.05*
Kt/V 1.6±0.3 1.5±0.3 1.6±0.3 <0.05*
C -reactive protein (mg/dl)
CPR > 0.6
1.0±1.3 (Median= 0.5)
69 (38.1%)
0.9±1.1 (Median= 0.5)
31 (37.8%)
1.0±1.5 (Median= 0.5)
38 (38.4%)
n.s.*
n.s.**
Note: Value are expressed: mean ± standard deviation and frequency (n, %)
p* test t -Student for independent samples, compared by sex; p** test Mann -Whitney for independent samples, compared by sex. Abbreviations: n.s., no significance
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 Patients ‘survival and causes of death
The mean survival time of patients was 32.7±19.3 
months, median 28.5 (range: 2 months to 6.25 years). 
The major causes of death were cardiovascular dis-
ease (35.4%) and infections (15.6%), all other causes 
accounting for the remainder 49%.
 Survival analysis
The influence of initial variable on mortality of 
the patients is shown in Table III.
Age over 60 years, Alb (lower than 3.8 g/dl), PA 
(lower than 4.9°) and BCMI lower than 8 kg/m2 were 
significantly associated with increased mortality. In 
contrast, gender and presence of diabetes did not 
influence mortality. Finally, protein intake lower than 
1.2 g/kg/day and inflammatory state (CPR>0.6 mg/dl) 
were also associated to reduced survival. Concerning 
the BIA parameters, PA (lower than 4.9°) and BCMI 
lower than 8 kg/m2 negatively influenced the survival, 
as shown in Figure 1 (Fig. 1).
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Table II
Comparison between survivor and non-survivor patients
Parameters
Survivor
(n = 85)
Non - survivor (n = 96) p*; p**
Demographic
Gender (M/F) n (%) 42 (49.4%) F
42 (49.4%) M
40 (41.7%) F
56 (58.3%) M n.s.*
Diabetes (%) 27.1% 30.2% n.s.*
Age (Years) 62.2 ± 13.2 68.9 ± 9.8 < 0.001**
Dialysis vintage (years) 4.2 ± 4.4 (Median = 2.8 y) 5.6 ± 4.7 (Median = 3.9 y) <0.05**
Parameters of protein -energy nutritional status
SGA (1 -7 point) 6.7 ± 0.4 6.6 ± 0.4 n.s.**
Serum albumin (g/dl) 3.9 ± 0.3 3.8 ± 0.3 n.s.**
Serum creatinine (mg/dl) 8.9 ± 2.7 8.4 ± 2.1 n.s.**
Total cholesterol (mg/dl) 155.2±35.8 150.6±33.4 n.s**
Body mass index (kg/m2) 24.6 ± 4.2 24.1 ± 3.5 n.s.**
Phase angle (º) _BIA 5.9 ± 1.4 5.2 ± 0.9 <0.001**
Body mass cell index (kg/m2) – BIA 8.2 ± 2.2 7.0 ± 1.2 <0.001**
Body Fat (%) 33.2 ± 8.7 32.8 ± 9.3 n.s.**
Fat -free mass (%) 66.8 ± 8.8 67.2 ± 9.3 n.s.**
Body mass cell (kg) 22.8 ± 7.0 21.4 ± 6.7 n.s.**
Extracellular mass/body cell mass ratio 0.9 ± 0.2 1.1 ± 0.2 <0.001**
Parameters of dialysis dose
Kt/V 1.6 ± 0.3 1.5 ± 0.3 n.s.**
Parameters of protein ingestion
PNAn (g/kg/day) 1.1 ± 0.1 1.0 ± 0.2 <0.001**
Parameters of inflammation
C -reactive protein (mg/dl) 0.6 ± 0.6 (Median = 0.1) 1.3 ± 1.7 (Median = 1.0) <0.001**
Note: Values are expressed as Mean ± SD; *p Mann -Whitney test for independent samples, compared by groups; **p student’s t test for independent samples, compared by 
groups; Abbreviations: n.s., not significant; F, Female; M, Male.
Table III
Influence of initial variable on mortality of patients
Parameters Odds Ratio 95% CI p
Sex 0.7 0.4 -1.3 n.s.
Diabetes 0.9 0.4 -1.6 n.s.
Smoking 4.8 1.0 -23.6 < 0.05
Age ≥ 60 years 0.4 0.2 -0.7 < 0.01
Dialysis vintage ≥ 2 years 0.4 0.2 -0.7 < 0.01
Alb ≤ 3.8 g/dl 1.9 0.9 -3.7 < 0.05
PA ≤ 4.9º 0.5 0.2 -1.0 < 0.01
BCMI ≤ 8 kg/m2 3.4 1.8 -6.2 < 0.01
PNAn ≤ 1.2 g/kg/day 2.7 1.5 -4.9 < 0.01
CRP > 0.6 mg/dl 0.2 0.1 -0.5 < 0.001
Mantel -Hansel odds ratio; Abbreviations: CI, confidence interval 
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In the univariate analysis, general factors includ-
ing age (HR:1.038; 95% CI, 1.005 to 1.071; p<0,05), 
dialysis vintage (HR:1.070; 95% CI 1.009 to 1.134; 
p<0,05), cardiovascular co-morbidity (HR:3.961; 
95% CI, 2.010 to 7.806; p<0,01) and PNAn 
(HR:0.625; 95% CI, 0.395 to 0.995; p<0,05) were 
all significant predictors of mortality. Among BIA 
nutritional parameters: BCMI (HR: 0.807; 95% CI 
0.672 to 0,970; p<0,05), PA (HR: 0.737; 95% CI, 
0.557 to 0.975; p<0,05) and ECM/BCM(log10) (HR: 
36.362; 95% CI, 1.138 to 1161.744; p<0,05) were 
also associated with reduced survival. The other 
parameter: SGA, presence of diabetes, Alb, 
CPR≥0.6 mg/dl and BMI, were not predictive of 
mortality. Selected for the multivariable Cox 
analysis variables were: age, dialysis vintage, PA, 
BCMI, presence of diabetes and cardiovascular 
co-morbidity, Alb, PNAn and CRP. As shown in 
Table IV, the PA was the only nutritional marker 
that was associated with mortality in the multi-
variate analysis.
 DISCUSSION
Protein energy wasting (PEW) is a relevant prob-
lem in HD patients and is associated with an 
increased risk of mortality and morbidity11-13. This 
retrospective study was performed to evaluate the 
clinical importance of BIA nutritional markers with 
regard to the prediction of mortality.The average 
age of the sample was 65.8 years, higher than the 
average age of HD patients in European countries 
(between 58.1 and 62.2) and the United States of 
America (USA) (which is about 60 years). This study 
confirms that advanced age is a well-known risk 
factor in HD patients. For example, in the USA, the 
median life expectancy among patients starting 
dialysis is only 2.5 years, for ages between 65 and 
69 years old is less than 1 year in ages >=85 years 
old14.
Diabetes was the primary cause of chronic kidney 
disease in the study sample, with 25.9% of diabetic 
patients. However, in this study, the diabetic condi-
tion did not influence the survival of patients. On 
the contrary, other studies have described Araujo et 
al., describe the presence of diabetes at the begin-
ning of treatment, as an independent factor for the 
increase of the mortality rate in the following 10 
years15. Hayashino et al. reported that diabetic 
patients on HD face a higher risk of mortality than 
nondiabetics (multivariate rate risk: 1.37, 95% CI, 
1.08 to 1.74.)16.
We found that patients with cardiovascular co-
morbidity have a higher risk of mortality. The studies 
confirm higher cardiovascular risk death in HD 
patients, even after adjustment for age and the pres-
ence of diabetes. Heart failure is a rapidly lethal 
condition, in patients with ESRD, which appears to 
mediate most of the negative prognostic impact of 
ischemic heart disease. Abnormalities of the left ven-
tricle are present at the start of dialysis in about 
80% of dialysis patients. This foresees future ischemic 
Predictive value of bioelectrical impedance analysis parameters 
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Table IV
Cox Hazards analysis of factors predicting mortality
Parameters B Hazard Ratio 95% CI p
Age (years) 0.340 1.038 1.005 -1.071 < 0.01
Dialysis vintage (years) 0.651 1.070 1.009 -1.134 < 0.05
Cardiovascular
Co -morbidity
0.422 3.961 2.010 -7.806 < 0.05
PA (º)  -2.753 0.737 0.557 -0.975 < 0.05
CRP (mg/dl) 0.885 2.423 1.452 -4.045 < 0.01
Cox proporcional Hazards analysis; Abbreviations: CI, confidence interval
Figure 1
Kaplan -Meier proportion of surviving patients comparing subgroups of 
severity according PA -BIA (cut -off PA = 4.9º) in 181 prevalent HD patients.
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heart disease, heart failure and death after 2 years 
of dialysis treatment17.
European3 and American18 recommendations 
advise the use of SGA as a tool for nutritional 
screening validity, for the population of patients in 
HD. The SGA has been used as the reference method, 
for the development of other instruments of nutri-
tional screening3,18. This study reveals that 11% of 
patients suffer from moderate malnourishment 
because of SGA. Gurreebun et al. found similar 
results in the study of 141 patients on HD, with only 
9.2% of malnourished patients19. The DOPPS20 
(2004) study indicates that the prevalence of severe 
malnutrition according to SGA ranges from 2.3% 
(Italy) to 11% (USA). The prevalence of moderate 
malnutrition ranges between 7.6% (USA) to 18% 
(France). In the USA sample, severely and moderately 
malnourished patients faced a higher mortality risk 
compared with those not malnourished, 33% and 
5% higher, respectively20. Chan et al. studied 167 
HD patients and found that age, hypoalbuminaemia 
and SGA scores are independent predictors of mor-
tality. Compared with being well nourished (SGA = 
A), malnourishment with normal or low Alb was 
associated with higher risk of mortality (HR: 2.06; 
95% CI, 1.06 to 4.00; p=0.03 and HR: 2.86; 95% 
CI, 1.65 to 4.94; p<0.0001, respectively)(21). However, 
this study demonstrated that the SGA is not a pre-
dictor of mortality in patients with HD. Others studies 
have demonstrated that decreased SGA was an 
independent predictor of mortality in hemodialysis 
patients34,35. On the other hand, the DOPPS study 
found no relation between PNAn and survival in US 
patients20.
Among the single laboratory markers, only CRP 
is a reliable prognostic parameter. Mutsert et al. 
studied 815 patients and found that in patients with 
either SGA score (HR: 1.6, 95% CI: 1.3 to 2.0), inflam-
mation (HR:1.6, CI 1.3 to 2.0) or CVD (HR:1.7, 1.4 to 
2.1) faced higher risk of mortality22.
We also identified low dietary protein intake, as 
estimated by PNAn<1.2 g/kg per day, to be an inde-
pendent risk factor for death. The influence on PNAn 
on survival of HD patients has been demonstrated 
by several previous studies23-26.
The measure of BIA may be used for the detection 
of malnutrition as well as the body fluid status. The 
PA is derived from the tangent arch, between reac-
tance and resistance, measured by BIA, and lower 
PA indicates low reactance, cell death, or loss of 
selective permeability of cell membrane27,28. Our 
study, the PA is correlated with other nutritional 
markers including Alb, Creat, SGA and BMI. Correlates 
negatively with CRP. Similar results were obtained 
in other studies29-31. PA and BCMI were significantly 
lower in the group of patients who do not survive. 
The low PA was identified as an independent factor 
for mortality risk, even when adjusted for other 
parameters such as age, dialysis vintage, cardiovas-
cular co-morbidities, diabetes, inflammation and 
other nutritional markers (Alb and PNAn). The relation 
between PA and mortality has been demonstrated 
in many studies30,32-34.
The BCMI is correlated with other nutritional mark-
ers including Alb, Creat, SGA and PNAn. It correlates 
negatively with CRP. The low BCMI was also identified 
as an independent risk factor for mortality but it did 
not enter the final Cox regression model, since it has 
a high correlation with PA (r=0,787). Talluri et al. 
describe BCMI as a more sensitive parameter than 
BMI to monitor changes in muscle mass and protein 
tissues, which might be associated with certain patho-
logical conditions. Thus, a wide application of this 
index is recommended35.
ECM/BCM ratio was significantly higher in the group 
of patients who do not survive. The ECM/BCM ratio 
correlated inversely with: Alb, Creat and SGA. The 
higher BCMI was also identified as an independent 
risk factor for mortality, but did not enter the final 
Cox regression model, since it has a high correlation 
with PA (r=-0.74; p<0.001). Avram et al. proposed 
the ECM/BCM ratio as prognostic marker in peritoneal 
dialysis patients. BCM reflects essentially muscle 
mass, whereas ECM corresponds to extracellular 
water. Thus, ECM/BCM ratios higher than 1.2 would 
indicate lower MM and/or fluid overload, which was 
associated in that higher mortality over follow-up of 
8 years10.
We conclude that the present study shows that 
BIA parameters (PA, BCMI and ECM/BCM ratios) and 
PNAn were the only nutritional markers associated 
with mortality in this sample of HD patients. In 
multivariate analysis, after adjusting for other mor-
tality risk factors, only patients with lower PA were 
found to face high risk for mortality at follow-up. 
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Fátima Silva, Francisco Travassos, Tânia Rodrigues, Orlando Pereira, Arlindo Azevedo, Rui Castro, Flora Correia
Nefro - 28-4 - MIOLO.indd   316 29/12/2014   14:18:24
Port J Nephrol Hypert 2014; 28(4): 309-317    317
CMYKP
Therefore we conclude that the bioelectrical imped-
ance analysis is a promising technique for assessing 
the nutritional status of patients on haemodialysis 
and may be used as a prognostic indicator of mor-
tality in this population.
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